Owens & Minor, Inc.(OMI)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $2.38 – $9.55
- YTD
- +0.00%
- IV Rank (30D)
- 47.04
- Straddle Price
- $0.68
- P/C Vol Ratio
- 0.83
- Market Cap
- $0.2B
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.00% |
| Beta vs SPY | 1.00 |
| Cost of Equity (CAPM) | 9.50% (VRP-adj) |
| WACC | 4.90% |
| Volatility Risk Premium | +188.0pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +5.2% |
| DCF Horizon | 5 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.05 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $-0.3B |
| Book / Price | -213.4% |
| Gross Margin (TTM) | 46.7% |
| FCF Margin (TTM) | -12.3% |
| Quality Score | 0/6 — cyclical/struggling (5y DCF) |
| SMA 50 | $2.83 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $2.81 |
| Bollinger Width / SMA20 | 583.2% (drives anchor stability) |
| Net Debt | $1.5B |
| Market Cap | $0B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | |
| Peer EV/EBITDA | n/a | 0% | |
| Peer P/B | n/a | 0% | |
| Peer P/S | n/a | 0% | |
| Market Anchor (SMA50) | $2.83 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
- Industry (SIC)
- WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES (5047)
- Exchange
- XNYS
- Market Cap
- $0.2B
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the…
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +4.02% | 22 |
| Feb | +0.03% | 22 |
| Mar | +0.91% | 23 |
| Apr | -3.40% | 22 |
| May | +0.31% | 22 |
| Jun | +1.96% | 22 |
| Jul | +5.21% | 22 |
| Aug | -1.20% | 22 |
| Sep | +1.69% | 22 |
| Oct | -5.30% | 22 |
| Nov | +0.98% | 22 |
| Dec | -1.57% | 22 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-08-02 | Pre-Market | 15.44% | 4.71% | 0.31x | Within |
| 2024-11-04 | Pre-Market | 21.09% | 0.93% | 0.04x | Within |
| 2025-02-03 | After-Close | 21.50% | 3.44% | 0.16x | Within |
| 2025-05-08 | Pre-Market | 18.42% | 9.95% | 0.54x | Within |
| 2025-08-11 | Pre-Market | 24.68% | 35.40% | 1.43x | Exceeded |
| 2025-10-30 | After-Close | 18.65% | 17.34% | 0.93x | Within |
- IV Rank (30D)
- 47.04
- IV Rank (7D)
- 47.04
- Avg IV
- 594.3%
- Straddle (30D)
- $0.68
- Straddle (7D)
- $0.68
- P/C Volume
- 0.83
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Enter a ticker to render the implied volatility surface.
- Beta (1Y vs SPY)
- 1.14
- Correlation (SPY)
- 15.4%
- R²
- 0.02
- Ann. Volatility
- 82.1%
- SPY Volatility
- 11.1%
Above average volatility - stock moves with market amplification
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2025-11-20 | Andrew G Long | EVP, CEO P&HS | Gift (G) | −47,908 | — | EDGAR | |
| 2025-09-24 | Jonathan A Leon | EVP & CFO | Tax (F) | −4,265 | $5.40 | -$23.0K | EDGAR |
| 2025-08-14 | Coliseum Capital Management, LLC | 10%+ Owner | Buy (P) | +7,689,260 | $5.27 | $40.50M | EDGAR |
| 2025-06-04 | Jennifer A Stone | EVP, CHRO | Tax (F) | −5,764 | $6.35 | -$36.6K | EDGAR |
| 2025-05-20 | Heath H Galloway | EVP,General Counsel & CorpSecy | Tax (F) | −1,768 | $7.38 | -$13.0K | EDGAR |
| 2025-05-16 | Michael Wayne Lowry | SVP, Corporate Controller | Tax (F) | −1,533 | $7.00 | -$10.7K | EDGAR |
| 2025-05-16 | Rita Johnson-Mills | Director | Award (A) | +28,914 | — | EDGAR | |
| 2025-05-16 | Andrew G Long | EVP, CEO P&HS | Tax (F) | −19,081 | $7.00 | -$133.6K | EDGAR |
| 2025-05-16 | Teresa L. Kline | Director | Award (A) | +28,914 | — | EDGAR | |
| 2025-05-16 | Perry A Bernocchi | EVP, CEO,. Patient Direct | Tax (F) | −13,394 | $7.00 | -$93.8K | EDGAR |
| 2025-05-16 | Carissa Rollins | Director | Award (A) | +28,914 | — | EDGAR | |
| 2025-05-16 | Kenneth Gardner-Smith | Director | Award (A) | +28,914 | — | EDGAR | |
| 2025-05-16 | Edward A Pesicka | President & CEO | Tax (F) | −35,208 | $7.00 | -$246.5K | EDGAR |
| 2025-05-16 | Gwendolyn M Bingham | Director | Grant (A) | +28,914 RSU | — | EDGAR | |
| 2025-05-16 | Jonathan A Leon | EVP & CFO | Tax (F) | −2,641 | $7.00 | -$18.5K | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Coliseum Capital Management, LLC | 10%+ Owner | 12,282,955 | $34.41M | $55.87M | 2 | 2025-08-14 |
| 2 | COLISEUM CAPITAL PARTNERS, L.P. | 10%+ Owner | 10,784,599 | $30.21M | $21.46M | 1 | 2025-04-07 |
| 3 | Christopher S Shackelton | 10%+ Owner | 9,824,599 | $27.52M | $136.93M | 1 | 2025-03-04 |
| 4 | Edward A Pesicka | President & CEO | 1,149,422 | $3.22M | -$26.09M | 33 | 2025-05-16 |
| 5 | Andrew G Long | EVP, CEO P&HS | 448,425 | $1.26M | -$944.6K | 25 | 2025-11-20 |
| 6 | PAUL CODY PHIPPS | President & CEO | 383,229 | $1.07M | $0 | 9 | 2018-07-03 |
| 7 | Nicholas J Pace | EVP, General Counsel | 267,095 | $748.2K | -$3.36M | 26 | 2023-05-17 |
| 8 | Perry A Bernocchi | EVP, CEO,. Patient Direct | 233,966 | $655.4K | -$1.30M | 14 | 2025-05-16 |
| 9 | Christopher M Lowery | Former Pres, Global Products | 232,120 | $650.2K | -$5.06M | 20 | 2022-04-04 |
| 10 | Jonathan A Leon | EVP & CFO | 218,522 | $612.1K | -$2.35M | 53 | 2025-09-24 |
| 11 | Jeffrey T Jochims | EVP, COO and | 203,956 | $571.3K | -$1.50M | 14 | 2022-07-05 |
| 12 | Shana Carol Neal | Chief Human Resources Officer | 158,594 | $444.3K | -$1.64M | 15 | 2022-03-07 |
| 13 | RICHARD A MEIER | EVP, Chief Financial Officer | 127,158 | $356.2K | $87.1K | 13 | 2018-02-12 |
| 14 | Stuart Raymond Morris-Hipkins | President | 123,864 | $347.0K | $0 | 5 | 2019-03-14 |
| 15 | ROBERT C SLEDD | Director | 121,990 | $341.7K | $861.7K | 19 | 2021-03-02 |
| 16 | Michael Wayne Lowry | SVP, Corporate Controller | 121,921 | $341.5K | -$2.70M | 71 | 2025-05-16 |
| 17 | Heath H Galloway | EVP,General Counsel & CorpSecy | 117,044 | $327.9K | -$178.7K | 12 | 2025-05-20 |
| 18 | Robert K Snead | EVP, CFO | 115,794 | $324.4K | $0 | 6 | 2019-05-20 |
| 19 | Joseph S Pekala | SVP, Chief Information Officer | 113,244 | $317.2K | $0 | 3 | 2019-12-11 |
| 20 | Jennifer A Stone | EVP, CHRO | 110,327 | $309.1K | $0 | 3 | 2025-06-04 |
| 21 | Snehashish Sarkar | EVP, Chief Information Officer | 108,586 | $304.2K | -$198.0K | 13 | 2025-05-16 |
| 22 | Daniel J Starck | EVP, Business Excellence | 95,612 | $267.8K | $0 | 5 | 2024-05-16 |
| 23 | JAMES L BIERMAN | President & CEO | 93,277 | $261.3K | -$396.8K | 24 | 2015-03-10 |
| 24 | ANNE M WHITTEMORE | Director | 84,839 | $237.7K | -$1.98M | 80 | 2020-01-02 |
| 25 | Robert J Henkel | Director | 77,412 | $216.9K | $523.3K | 36 | 2025-05-16 |
| 26 | JAMES E UKROP | Director | 74,610 | $209.0K | $0 | 8 | 2011-02-28 |
| 27 | Mark P Zacur | EVP, Chief Commercial Officer | 71,769 | $201.0K | -$1.34M | 5 | 2021-06-07 |
| 28 | ERIKA T DAVIS | SVP, Chief Administr. Officer | 71,610 | $200.6K | -$5.07M | 58 | 2019-03-06 |
| 29 | JOHN T CROTTY | Director | 63,037 | $176.6K | $0 | 6 | 2010-11-24 |
| 30 | EDDIE N JR MOORE | Director | 61,893 | $173.4K | -$1.10M | 90 | 2021-04-02 |
| 31 | Stephen W Klemash | Director | 59,051 | $165.4K | $0 | 6 | 2025-05-16 |
| 32 | JAMES E ROGERS | Director | 58,991 | $165.3K | -$991.6K | 24 | 2017-06-21 |
| 33 | GRACE R DENTTARTOG | SVP, General Counsel | 55,724 | $156.1K | -$2.92M | 44 | 2016-02-09 |
| 34 | Kenneth Gardner-Smith | Director | 54,922 | $153.9K | $0 | 5 | 2025-05-16 |
| 35 | Rita Johnson-Mills | Director | 54,125 | $151.6K | $0 | 4 | 2025-05-16 |
| 36 | Teresa L. Kline | Director | 54,125 | $151.6K | $0 | 4 | 2025-05-16 |
| 37 | Carissa Rollins | Director | 53,902 | $151.0K | $0 | 4 | 2025-05-16 |
| 38 | EV III Clarke | Exec. VP, Supply Chain | 50,761 | $142.2K | -$762.1K | 11 | 2011-04-29 |
| 39 | Alexander J Bruni | EVP, CFO | 49,950 | $139.9K | -$410.3K | 8 | 2024-06-04 |
| 40 | Michael C Riordan | Director | 48,707 | $136.4K | $273.4K | 4 | 2021-05-03 |
| 41 | Rony Camil Kordahi | EVP, North American Operations | 47,185 | $132.2K | -$71.6K | 7 | 2018-04-05 |
| 42 | Tammy L Gomez | EVP, CHRO | 46,782 | $131.1K | $0 | 3 | 2023-08-16 |
| 43 | BARBARA B HILL | Director | 46,738 | $130.9K | $0 | 30 | 2019-07-02 |
| 44 | A MARSHALL ACUFF | Director | 46,101 | $129.1K | $0 | 14 | 2013-02-15 |
| 45 | CHARLES C COLPO | SVP, Strategic Supplier Mgmt | 45,872 | $128.5K | -$6.33M | 65 | 2019-03-06 |
| 46 | Timothy P Connolly | EVP, Operations & Supply Chain | 42,808 | $119.9K | $0 | 1 | 2018-06-26 |
| 47 | Geoff Taylor Marlatt | SVP, Manufacturer Services | 42,607 | $119.4K | -$317.6K | 19 | 2019-03-06 |
| 48 | OLWEN B CAPE | Vice President, Controller | 40,717 | $114.1K | -$855.0K | 18 | 2010-04-28 |
| 49 | Mark A Beck | Director | 40,068 | $112.2K | -$161.2K | 15 | 2025-05-16 |
| 50 | Richard W Mears | SVP, Chief Information Officer | 35,664 | $99.9K | -$1.35M | 33 | 2016-10-04 |
| 51 | JOHN W GERDELMAN | Director | 35,635 | $99.8K | $0 | 13 | 2018-10-02 |
| 52 | Daniel Todd Healy | SVP, Provider Services | 33,674 | $94.3K | $0 | 5 | 2015-04-28 |
| 53 | G GILMER III MINOR | Director | 29,350 | $82.2K | -$11.38M | 30 | 2013-02-27 |
| 54 | STUART ESSIG | Director | 27,585 | $77.3K | $500.0K | 20 | 2019-07-02 |
| 55 | Martha H. Marsh | Director | 26,420 | $74.0K | $0 | 6 | 2018-05-18 |
| 56 | PETER S REDDING | Director | 25,713 | $72.0K | -$864.1K | 59 | 2012-04-02 |
| 57 | MARK A VAN SUMEREN | SVP, Strategy & Business Devel | 25,398 | $71.1K | -$2.54M | 36 | 2014-02-10 |
| 58 | Gwendolyn M Bingham | Director | 22,184 | $62.1K | -$268.4K | 8 | 2025-05-16 |
| 59 | Stephen Russell Olive | SVP, Chief Information Officer | 20,607 | $57.7K | $0 | 3 | 2018-02-12 |
| 60 | Brian J Shotto | SVP, Manufacturer Services | 19,416 | $54.4K | $0 | 5 | 2014-02-11 |
| 61 | JEFFREY KACZKA | SVP, Chief Financial Officer | 18,801 | $52.7K | $0 | 1 | 2007-02-05 |
| 62 | Michael Jay Romans | SVP, Human Resources | 14,698 | $41.2K | $0 | 4 | 2017-03-01 |
| 63 | Scott W Perkins | VP, West | 14,505 | $40.6K | -$589.0K | 12 | 2009-02-05 |
| 64 | William Marshall Simpson | EVP, Chief Commercial Officer | 14,204 | $39.8K | -$1.95M | 22 | 2016-02-09 |
| 65 | RICHARD F BOZARD | Vice President, Treasurer | 12,606 | $35.3K | -$889.8K | 13 | 2009-02-05 |
| 66 | CRAIG R SMITH | Director | 10,758 | $30.1K | -$31.15M | 83 | 2017-05-03 |
| 67 | DAVID S SIMMONS | Director | 10,721 | $30.0K | $72.0K | 11 | 2018-04-02 |
| 68 | Lemuel E Lewis | Director | 10,355 | $29.0K | $0 | 99 | 2019-04-02 |
| 69 | D ANDREW EDWARDS | VP, Controller & | 7,732 | $21.7K | $0 | 7 | 2013-02-06 |
| 70 | RICHARD E FOGG | Director | 5,516 | $15.5K | -$1.28M | 74 | 2014-01-02 |
| 71 | Aster Angagaw | Director | 4,708 | $13.2K | $0 | 2 | 2021-05-03 |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
| TTM Revenue | $2.8B |
| TTM Net Income | $-1.1B |
| TTM EPS | $-14.32 |